NiteHush Pro is rapidly emerging as the go-to solution for those struggling with persistent snoring and dangerous sleep apnea ...

A bill approved by the Alabama Senate sets a $10 drug dispensing fee for pharmacists while also seeking to regulate the ...

Baltimore’s lawsuit against two sports betting giants marks city leaders’ latest effort to challenge the massive companies ...

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers over insulin pricing practices will likely move ...

STAT reports that the administration is planning on disrupting the fentanyl supply chain in order to reduce overdose deaths. The drug policy document is not public yet. More news is on South African ...

A Canadian study finds those who seek medical care at a hospital after using hallucinogens nearly three times more likely to ...

A House panel Wednesday approved a bill aimed at preventing pharmacy benefit managers from holding a permit to operate a drug store in Arkansas. The Federal Trade Commission released an interim report ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

Moderna, Baxter, and Pfizer are our top healthcare picks.

Biotech stocks face a tough 2025 with SMid-cap losses up to 40% YTD. BofA cites FDA changes, tariffs, and capital struggles but notes potential opportunities.